MiMARK Diagnostics — Seed · approximately €1.72M

MiMARK Diagnostics, a Vall d'Hebron Research Institute spin-off developing protein-based gynaecological diagnostics such as its WomEC endometrial cancer test, announced the close of its first seed round at €4.22M. CDTI Innvierte, Inveready and Canterbury Scientific joined in the final close, after a first close with Clave Capital, Nara Capital, Namarel Ventures and WA4STEAM; the total includes €2.5M from the EIC Accelerator, and no single lead was named. The €2.5M EIC Accelerator grant is filed separately as a grant, so this round records the equity, about €1.72M.